Industry News

Our news page will keep you informed of press releases and news articles on rapid and alternative microbiological method technologies and updates from technology suppliers.

Please click here to submit your news.

Takara Bio Partners with Pathogenica For HAI Sequencing Service in Japan

Takara Bio Inc. has announced an agreement with Pathogenica Inc., based in Boston, to market and distribute the Pathogenica HAI (Hospital Acquired Infection) BioDetection Kit in Japan. The kit is currently being sold for research use and is the first DNA sequencing analysis product that enables identification of infectious diseases with sequence-specific resolution at a scale that makes hospital-wide screening practical.

Hospital acquired infections are a globally recognized health problem, and Pathogenica's HAI BioDetection Kit enables health care providers to rapidly characterize, track, and deal with the causative agents, preserving the health of patients and helping hospitals reduce the cost of care.

Current methods for pathogen identification can take days to obtain results or are limited to a few organisms. The Pathogenica solution quickly identifies what species are present in a sample and also provides sequence data (including strain identity and resistance genes), which is critical information for understanding and containing or preventing outbreaks. The kit can detect 12 bacteria commonly associated with HAIs and 15 resistance gene families in a single assay and 12 samples can be processed per sequencing run. The kit offers an impressive "sample to result" turnaround of less than 12 hours and detects co-infections with a high degree of reliability.

In addition to selling kits, Takara Bio is offering sequencing services through its state-of-the art Dragon Genomics Center, enabling doctors and epidemiologists to send samples out to Takara, have them sequenced, and receive back the interpreted information on microbial characterization. The Pathogenica HAI solution combined with Takara Bio's sequencing service allows healthcare and research facilities of all sizes to leverage sequencing technology for obtaining useful findings to track HAIs, control outbreaks, and improve quality of care.

All products referenced are for Research Use Only and not intended for diagnostic purposes.

Post a Comment

Previous Post Next Post

Contact Form